Authors: Demir, G Ozguroglu, M Sayhan, N Molinas-Mandel, N Demirelli, F Buyukunal, E Tuzuner, N Serdengecti, S Berkarda, B

Citation: G. Demir et al., Immunomodulating therapy with rIL-2 and interferon alpha induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (A pilot study), ANTICANC R, 19(4C), 1999, pp. 3517-3520

Authors: Demir, G Demirelli, F Ozguroglu, M Molinas-Mandel, N Buyukunal, E Tuzuner, N Serdengecti, S Berkarda, B

Citation: G. Demir et al., Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma, INT J IMM T, 14(3), 1998, pp. 163-168